• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于亚型与分布相结合的胃黏膜肠化生分级新方法。

A novel method of grading gastric intestinal metaplasia based on the combination of subtype and distribution.

作者信息

Wei Ning, Zhong Zhiheng, Shi Ruihua

机构信息

Medical School of Southeast University, No. 87 Dingjiaqiao,, Nanjing, 210009, China.

Department of Gastroenterology, Southeast University Affiliated Zhongda Hospital, No. 87 Dingjiaqiao, Nanjing, 210009, China.

出版信息

Cancer Cell Int. 2021 Jan 20;21(1):61. doi: 10.1186/s12935-021-01758-6.

DOI:10.1186/s12935-021-01758-6
PMID:33472622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7816327/
Abstract

BACKGROUND

Studies have shown the value of subtypes and distribution of gastric intestinal metaplasia (GIM) for prediction of gastric cancer. We aim to combine GIM subtypes and distribution to form a new scoring system for GIM.

METHODS

This was a cross-sectional study. No GIM, type I, II, and III GIM of gastric antrum and corpus scored 0-3 points respectively. Then the severity of the whole stomach was calculated in two ways: 1. The gastric antrum and corpus scores were added together, with a score ranging from 0 to 6, which named "Subtype Distribution Score of Gastric Intestinal Metaplasia (SDSGIM)". 2. Direct classification according to a table corresponding to that of OLGIM. We compared the SDSGIM among benign lesions, dysplasia, and cancer and drew receiver operating characteristic (ROC) curve to determine the optimal cut-off value. According to the cut-off value and the classification from the table, the predictive ability of these two methods were calculated.

RESULTS

227 patients were included. For SDSGIM, benign lesion group was significantly different from dysplasia or cancer group. Area under curve of ROC curve was 0.889 ± 0.023. The optimal cut-off value was 3. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of SDSGIM for malignancy were 89.5%, 78.0%, 74.6%, 91.2% and 82.8%. And those for the second classification method were 84.2%, 82.6%, 77.7%, 87.9%, and 83.3% respectively.

CONCLUSIONS

This study firstly combined GIM subtypes with its distribution forming a novel scoring system, which showed high prediction accuracy for malignant lesions.

摘要

背景

研究表明胃化生(GIM)的亚型和分布对于预测胃癌具有重要价值。我们旨在将GIM亚型和分布结合起来,形成一种新的GIM评分系统。

方法

这是一项横断面研究。胃窦和胃体的无GIM、I型、II型和III型GIM分别计0 - 3分。然后通过两种方式计算全胃的严重程度:1. 将胃窦和胃体的分数相加,得分范围为0至6分,称为“胃化生亚型分布评分(SDSGIM)”。2. 根据与OLGIM相对应的表格进行直接分类。我们比较了良性病变、发育异常和癌症之间的SDSGIM,并绘制了受试者工作特征(ROC)曲线以确定最佳截断值。根据截断值和表格中的分类,计算这两种方法的预测能力。

结果

纳入227例患者。对于SDSGIM,良性病变组与发育异常或癌症组有显著差异。ROC曲线下面积为0.889±0.023。最佳截断值为3。SDSGIM对恶性肿瘤的敏感性、特异性、阳性预测值、阴性预测值和准确性分别为89.5%、78.0%、74.6%、91.2%和82.8%。而第二种分类方法的相应值分别为84.2%、82.6%、77.7%、87.9%和83.3%。

结论

本研究首次将GIM亚型与其分布相结合,形成了一种新的评分系统,对恶性病变具有较高的预测准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad62/7816327/1e263a1cc061/12935_2021_1758_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad62/7816327/e1393a753b4e/12935_2021_1758_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad62/7816327/1e263a1cc061/12935_2021_1758_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad62/7816327/e1393a753b4e/12935_2021_1758_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad62/7816327/1e263a1cc061/12935_2021_1758_Fig2_HTML.jpg

相似文献

1
A novel method of grading gastric intestinal metaplasia based on the combination of subtype and distribution.一种基于亚型与分布相结合的胃黏膜肠化生分级新方法。
Cancer Cell Int. 2021 Jan 20;21(1):61. doi: 10.1186/s12935-021-01758-6.
2
Gastric intestinal metaplasia assessment between linked color imaging based on endoscopy and pathology.基于内镜检查和病理学的联合彩色成像对胃黏膜肠化生的评估
Scand J Gastroenterol. 2021 Jan;56(1):103-110. doi: 10.1080/00365521.2020.1849385. Epub 2020 Nov 24.
3
Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study.内镜胃肠上皮化生分级(EGGIM):一项多中心验证研究。
Endoscopy. 2019 Jun;51(6):515-521. doi: 10.1055/a-0808-3186. Epub 2018 Dec 21.
4
Carbon footprint and cost reduction by endoscopic grading of gastric intestinal metaplasia using narrow-band imaging.使用窄带成像对胃化生进行内镜分级以减少碳足迹和成本
J Gastroenterol Hepatol. 2024 May;39(5):942-948. doi: 10.1111/jgh.16493. Epub 2024 Jan 22.
5
Reliability and accuracy of blue light imaging for staging of intestinal metaplasia in the stomach.蓝光成像用于胃肠化生分期的可靠性和准确性。
Scand J Gastroenterol. 2019 Nov;54(11):1301-1305. doi: 10.1080/00365521.2019.1684555. Epub 2019 Nov 3.
6
A single vial is enough in the absence of endoscopic suspected intestinal metaplasia - less is more!在没有内镜检查怀疑肠化生的情况下,单瓶就足够了——少即是多!
Scand J Gastroenterol. 2019 May;54(5):673-677. doi: 10.1080/00365521.2019.1613443. Epub 2019 May 13.
7
The Distribution of Incomplete Gastric Intestinal Metaplasia (GIM) Subtype among Biopsy Sites according to the Updated Sydney System and Its Association with GIM Extension.根据更新的悉尼系统,不完全性胃化生(GIM)亚型在活检部位的分布及其与GIM扩展的关联。
Gastroenterol Res Pract. 2018 May 8;2018:4938730. doi: 10.1155/2018/4938730. eCollection 2018.
8
Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.胃蛋白酶原用于在胃癌高危人群中鉴别肠化生和幽门螺杆菌感染患者
Clin Transl Gastroenterol. 2016 Jul 21;7(7):e183. doi: 10.1038/ctg.2016.42.
9
Can neopterin be a useful immune biomarker for differentiating gastric intestinal metaplasia and gastric atrophy from non-atrophic non-metaplastic chronic gastritis?新蝶呤能否作为一种有用的免疫生物标志物,用于区分胃肠化生和胃萎缩与非萎缩性非化生慢性胃炎?
Gastroenterol Hepatol. 2019 May;42(5):289-295. doi: 10.1016/j.gastrohep.2019.01.005. Epub 2019 Feb 20.
10
A spatially mapped gene expression signature for intestinal stem-like cells identifies high-risk precursors of gastric cancer.一种用于肠道干细胞样细胞的空间映射基因表达特征可识别胃癌的高危前体。
bioRxiv. 2023 Sep 22:2023.09.20.558462. doi: 10.1101/2023.09.20.558462.

引用本文的文献

1
History of chronic gastritis: How our perceptions have changed.慢性胃炎的历史:我们的认知是如何改变的。
World J Gastroenterol. 2024 Apr 7;30(13):1851-1858. doi: 10.3748/wjg.v30.i13.1851.
2
Chronic Autoimmune Gastritis: Modern Diagnostic Principles.慢性自身免疫性胃炎:现代诊断原则
Diagnostics (Basel). 2021 Nov 15;11(11):2113. doi: 10.3390/diagnostics11112113.
3
Correction to: A novel method of grading gastric intestinal metaplasia based on the combination of subtype and distribution.对《基于亚型与分布相结合的胃肠化生分级新方法》的更正

本文引用的文献

1
Biopsy strategies for endoscopic screening of pre-malignant gastric lesions.内镜筛查胃前病变的活组织检查策略。
Sci Rep. 2019 Oct 17;9(1):14909. doi: 10.1038/s41598-019-51487-0.
2
British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.英国胃肠病学会关于胃腺癌风险患者的诊断和管理指南。
Gut. 2019 Sep;68(9):1545-1575. doi: 10.1136/gutjnl-2018-318126. Epub 2019 Jul 5.
3
Dynamics of infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial.
Cancer Cell Int. 2021 Feb 24;21(1):132. doi: 10.1186/s12935-021-01787-1.
感染动力学作为胃癌前病变进展的决定因素:一项根除试验的 16 年随访。
Gut. 2018 Jul;67(7):1239-1246. doi: 10.1136/gutjnl-2016-311685. Epub 2017 Jun 24.
4
Anatomical predilection of intestinal metaplasia based on 78,335 endoscopic cases.基于78335例内镜检查病例的肠化生解剖学倾向
Saudi J Gastroenterol. 2016 Mar-Apr;22(2):154-60. doi: 10.4103/1319-3767.178528.
5
Body mass index and risk of gastric cancer: a meta-analysis.体重指数与胃癌风险:一项荟萃分析。
Jpn J Clin Oncol. 2014 Sep;44(9):783-91. doi: 10.1093/jjco/hyu082. Epub 2014 Jun 20.
6
A meta-analysis on alcohol drinking and gastric cancer risk.饮酒与胃癌风险的荟萃分析。
Ann Oncol. 2012 Jan;23(1):28-36. doi: 10.1093/annonc/mdr135. Epub 2011 May 2.